activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	3358753	CHEMBL1175219	Inhibition of PIP5K2C at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL1770034	Homo sapiens	INH	%	100.0
	3358753	CHEMBL1175219	Inhibition of PIP5K2C at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL1770034	Homo sapiens	INH	%	100.0
	3359195	CHEMBL1175219	Inhibition of PIP5K2C at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL1770034	Homo sapiens	INH	%	100.0
	3407766	CHEMBL1219797	Inhibition of PIP5K2C at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	<	Inhibition	%	10.0	CHEMBL1770034	Homo sapiens	INH	%	10.0
	3407767	CHEMBL1219797	Inhibition of PIP5K2C at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	<	Inhibition	%	10.0	CHEMBL1770034	Homo sapiens	INH	%	10.0
	6183787	CHEMBL1772044	Binding affinity to human PIP5K2C 	B	Cc1nc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1435542	=	Kd	nM	280.0	CHEMBL1770034	Homo sapiens	Kd	nM	280.0
	6183791	CHEMBL1772044	Binding affinity to human PIP5K2C 	B	c1nc(NCC2CCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1436585	=	Kd	nM	310.0	CHEMBL1770034	Homo sapiens	Kd	nM	310.0
	6183798	CHEMBL1772044	Binding affinity to human PIP5K2C 	B	Cc1nc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1474834	=	Kd	nM	360.0	CHEMBL1770034	Homo sapiens	Kd	nM	360.0
	7567553	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7568024	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7568492	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	230.0	CHEMBL1770034	Homo sapiens	Kd	nM	230.0
	7568924	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7569067	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7569527	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7569999	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	380.0	CHEMBL1770034	Homo sapiens	Kd	nM	380.0
	7570462	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7570889	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7571043	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7571500	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7571976	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7572439	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	620.0	CHEMBL1770034	Homo sapiens	Kd	nM	620.0
	7573024	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	110.0	CHEMBL1770034	Homo sapiens	Kd	nM	110.0
	7573481	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7573957	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7574392	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	2300.0	CHEMBL1770034	Homo sapiens	Kd	nM	2300.0
	7575002	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7575463	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1000.0	CHEMBL1770034	Homo sapiens	Kd	nM	1000.0
	7575957	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7576365	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	530.0	CHEMBL1770034	Homo sapiens	Kd	nM	530.0
	7576976	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7577435	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	28.0	CHEMBL1770034	Homo sapiens	Kd	nM	28.0
	7577471	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7577941	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7578346	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	4100.0	CHEMBL1770034	Homo sapiens	Kd	nM	4100.0
	7578984	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7579358	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7579840	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7580309	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	780.0	CHEMBL1770034	Homo sapiens	Kd	nM	780.0
	7580712	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7581730	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	870.0	CHEMBL1770034	Homo sapiens	Kd	nM	870.0
	7582201	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7582665	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7583065	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7583246	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7583643	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7584088	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7584559	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7585021	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	120.0	CHEMBL1770034	Homo sapiens	Kd	nM	120.0
	7585425	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7585576	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7585984	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7586430	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7586901	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7587355	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7587537	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7587956	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7588409	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	7500.0	CHEMBL1770034	Homo sapiens	Kd	nM	7500.0
	7588880	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7589502	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7589926	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7590393	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7590876	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7591475	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7591897	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7592369	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7592400	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7592853	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	=	Kd	nM	3300.0	CHEMBL1770034	Homo sapiens	Kd	nM	3300.0
	7593442	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7593877	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7594380	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7594832	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7595410	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7595886	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7596357	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	8800.0	CHEMBL1770034	Homo sapiens	Kd	nM	8800.0
	7596804	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7597382	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7597393	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7597866	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	7598336	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	280.0	CHEMBL1770034	Homo sapiens	Kd	nM	280.0
	7598778	CHEMBL1908831	Binding constant for PIP5K2C kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL1770034	Homo sapiens	Kd	nM	10000.0
	8003536	CHEMBL1942474	Inhibition of human PIP4K2C in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	8003537	CHEMBL1942474	Inhibition of human PIP4K2C in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	8003538	CHEMBL1942474	Inhibition of human PIP4K2C in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	8003539	CHEMBL1942474	Inhibition of human PIP4K2C in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	12172264	CHEMBL2212494	Inhibition of PIP5K2C assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL1770034	Homo sapiens	Activity	%	100.0
	12185210	CHEMBL2211988	Inhibition of PIP4K2C	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	=	IC50	nM	1071.52	CHEMBL1770034	Homo sapiens	pIC50		5.97
	13342435	CHEMBL2394162	Competitive binding affinity to PIP5K2C (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	10.0	CHEMBL1770034	Homo sapiens	Activity	%	10.0
	13414790	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414791	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414792	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414793	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414794	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414795	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414796	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	=	Inhibition	%	44.5	CHEMBL1770034	Homo sapiens	INH	%	44.5
	13414797	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414798	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414799	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	=	Inhibition	%	51.0	CHEMBL1770034	Homo sapiens	INH	%	51.0
	13414800	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	=	Inhibition	%	78.1	CHEMBL1770034	Homo sapiens	INH	%	78.1
	13414801	CHEMBL2424040	Inhibition of PIP4K2C in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	=	Inhibition	%	90.1	CHEMBL1770034	Homo sapiens	INH	%	90.1
	13414910	CHEMBL2424254	Inhibition of PIP4K2C in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O[C@H]1CC[C@H](Nc2nc3ccccc3n3ccnc23)CC1		CHEMBL2420582	=	Inhibition	%	50.9	CHEMBL1770034	Homo sapiens	INH	%	50.9
	13414911	CHEMBL2424254	Inhibition of PIP4K2C in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	c1ccc(CNc2nc3ccccc3n3ccnc23)cc1		CHEMBL2420578	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13414912	CHEMBL2424254	Inhibition of PIP4K2C in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	c1ccc(CCNc2nc3ccccc3n3ccnc23)cc1		CHEMBL2420577	=	Inhibition	%	52.6	CHEMBL1770034	Homo sapiens	INH	%	52.6
	13414913	CHEMBL2424254	Inhibition of PIP4K2C in human PC3 cell lysates at 30 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	c1ccc2c(c1)nc(NC1CCCCC1)c1nccn12		CHEMBL2420576	<	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	13895010	CHEMBL3111942	Inhibition of PIP5K2C (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	O=C(Nc1ccc(CO)cc1)Nc1ccc(-c2nc(N3CCOCC3)c3ncccc3n2)cc1		CHEMBL3109142	=	Activity	%	87.0	CHEMBL1770034	Homo sapiens	Activity	%	87.0
	15728404	CHEMBL3624245	Inhibition of PIP5K2C (unknown origin) at 10 uM	B	COc1ccc(-c2cnccc2-c2cnc(NC(=O)C(C)C)s2)c(C(F)(F)F)c1		CHEMBL3623443	>	Inhibition	%	90.0	CHEMBL1770034	Homo sapiens	INH	%	90.0
	16372009	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccccc3)c12		CHEMBL1371147	=	Kd	nM	3550.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.55
	16372010	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccccc3F)c12		CHEMBL1404898	=	Kd	nM	6310.0	CHEMBL1770034	Homo sapiens	Kd	uM	6.31
	16372011	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(F)c3)c12		CHEMBL1490041	=	Kd	nM	6310.0	CHEMBL1770034	Homo sapiens	Kd	uM	6.31
	16372012	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(F)cc3)c12		CHEMBL1378851	=	Kd	nM	12590.0	CHEMBL1770034	Homo sapiens	Kd	uM	12.59
	16372013	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccccc3Cl)c12		CHEMBL1526989	=	Kd	nM	14120.0	CHEMBL1770034	Homo sapiens	Kd	uM	14.12
	16372014	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(Cl)c3)c12		CHEMBL1435847	=	Kd	nM	11220.0	CHEMBL1770034	Homo sapiens	Kd	uM	11.22
	16372015	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(Cl)cc3)c12		CHEMBL1396351	=	Kd	nM	28180.0	CHEMBL1770034	Homo sapiens	Kd	uM	28.18
Not Determined	16372016	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccccc3Br)c12		CHEMBL1554155		Kd			CHEMBL1770034	Homo sapiens	Kd		
	16372017	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(Br)c3)c12		CHEMBL1437083	=	Kd	nM	2820.0	CHEMBL1770034	Homo sapiens	Kd	uM	2.82
	16372018	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(Br)cc3)c12		CHEMBL1553183	=	Kd	nM	39810.0	CHEMBL1770034	Homo sapiens	Kd	uM	39.81
	16372019	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccccc3C(F)(F)F)c12		CHEMBL1436077	=	Kd	nM	63090.0	CHEMBL1770034	Homo sapiens	Kd	uM	63.09
	16372020	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(C(F)(F)F)c3)c12		CHEMBL1496788	=	Kd	nM	6300.0	CHEMBL1770034	Homo sapiens	Kd	uM	6.3
	16372021	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(C(F)(F)F)cc3)c12		CHEMBL1315789	>	Kd	nM	100000.0	CHEMBL1770034	Homo sapiens	Kd	uM	100.0
	16372022	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1ccccc1-c1csc2ncnc(Sc3nnnn3C)c12		CHEMBL1315320	=	Kd	nM	44670.0	CHEMBL1770034	Homo sapiens	Kd	uM	44.67
	16372023	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1cccc(-c2csc3ncnc(Sc4nnnn4C)c23)c1		CHEMBL1592304	=	Kd	nM	11220.0	CHEMBL1770034	Homo sapiens	Kd	uM	11.22
	16372024	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1ccc(-c2csc3ncnc(Sc4nnnn4C)c23)cc1		CHEMBL1590625	=	Kd	nM	14120.0	CHEMBL1770034	Homo sapiens	Kd	uM	14.12
	16372025	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	COc1ccccc1-c1csc2ncnc(Sc3nnnn3C)c12		CHEMBL1516227	=	Kd	nM	79430.0	CHEMBL1770034	Homo sapiens	Kd	uM	79.43
	16372026	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	COc1cccc(-c2csc3ncnc(Sc4nnnn4C)c23)c1		CHEMBL1396223	=	Kd	nM	3980.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.98
	16372027	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	COc1ccc(-c2csc3ncnc(Sc4nnnn4C)c23)cc1		CHEMBL1486329	=	Kd	nM	11220.0	CHEMBL1770034	Homo sapiens	Kd	uM	11.22
	16372028	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccccc3C#N)c12		CHEMBL1436204	=	Kd	nM	6300.0	CHEMBL1770034	Homo sapiens	Kd	uM	6.3
	16372029	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(C#N)c3)c12		CHEMBL1597259	=	Kd	nM	2510.0	CHEMBL1770034	Homo sapiens	Kd	uM	2.51
	16372030	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(C#N)cc3)c12		CHEMBL1484208	=	Kd	nM	12590.0	CHEMBL1770034	Homo sapiens	Kd	uM	12.59
	16372031	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccccc3[N+](=O)[O-])c12		CHEMBL1593817	=	Kd	nM	11220.0	CHEMBL1770034	Homo sapiens	Kd	uM	11.22
	16372032	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc([N+](=O)[O-])c3)c12		CHEMBL1324313	=	Kd	nM	1580.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.58
	16372033	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc([N+](=O)[O-])cc3)c12		CHEMBL1415412	=	Kd	nM	6310.0	CHEMBL1770034	Homo sapiens	Kd	uM	6.31
	16372034	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(N)c3)c12		CHEMBL1317123	=	Kd	nM	3980.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.98
	16372035	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(N)cc3)c12		CHEMBL1397580	=	Kd	nM	5620.0	CHEMBL1770034	Homo sapiens	Kd	uM	5.62
	16372036	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CC(=O)c1ccccc1-c1csc2ncnc(Sc3nnnn3C)c12		CHEMBL1456711	=	Kd	nM	44670.0	CHEMBL1770034	Homo sapiens	Kd	uM	44.67
Not Determined	16372037	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CC(=O)c1cccc(-c2csc3ncnc(Sc4nnnn4C)c23)c1		CHEMBL1473985		Kd			CHEMBL1770034	Homo sapiens	Kd		
Not Determined	16372038	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CC(=O)c1ccc(-c2csc3ncnc(Sc4nnnn4C)c23)cc1		CHEMBL1571036		Kd			CHEMBL1770034	Homo sapiens	Kd		
	16372039	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(S(C)(=O)=O)c3)c12		CHEMBL1378392	=	Kd	nM	630.0	CHEMBL1770034	Homo sapiens	Kd	uM	0.63
	16372040	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(S(C)(=O)=O)cc3)c12		CHEMBL1516307	=	Kd	nM	7940.0	CHEMBL1770034	Homo sapiens	Kd	uM	7.94
	16372041	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(C(=O)OC(C)(C)C)cc3)c12		CHEMBL1407773	>	Kd	nM	100000.0	CHEMBL1770034	Homo sapiens	Kd	uM	100.0
Not Determined	16372042	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cnc(N)nc3)c12		CHEMBL1473735		Kd			CHEMBL1770034	Homo sapiens	Kd		
	16372043	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc(-c4ccccc4)cc3)c12		CHEMBL1528672	>	Kd	nM	100000.0	CHEMBL1770034	Homo sapiens	Kd	uM	100.0
	16372044	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccs3)c12		CHEMBL1328990	=	Kd	nM	2820.0	CHEMBL1770034	Homo sapiens	Kd	uM	2.82
	16372045	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccsc3)c12		CHEMBL1475514	=	Kd	nM	7940.0	CHEMBL1770034	Homo sapiens	Kd	uM	7.94
	16372046	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc[nH]3)c12		CHEMBL1394653	=	Kd	nM	5620.0	CHEMBL1770034	Homo sapiens	Kd	uM	5.62
	16372047	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cc4ccccc4o3)c12		CHEMBL1476017	=	Kd	nM	2820.0	CHEMBL1770034	Homo sapiens	Kd	uM	2.82
	16372048	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc4ccccc4c3)c12		CHEMBL1593156	=	Kd	nM	63090.0	CHEMBL1770034	Homo sapiens	Kd	uM	63.09
	16372049	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc4ccccc34)c12		CHEMBL1325058	>	Kd	nM	100000.0	CHEMBL1770034	Homo sapiens	Kd	uM	100.0
	16372050	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc4c(c3)OCO4)c12		CHEMBL1359120	=	Kd	nM	12590.0	CHEMBL1770034	Homo sapiens	Kd	uM	12.59
	16372051	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3ccc4c(=O)ccoc4c3)c12		CHEMBL1358682	=	Kd	nM	1990.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.99
	16372052	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc4c3sc3ccccc34)c12		CHEMBL1319866	>	Kd	nM	100000.0	CHEMBL1770034	Homo sapiens	Kd	uM	100.0
	16372053	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(Br)c12		CHEMBL1436389	=	Kd	nM	1120.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.12
	16372054	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(I)c12		CHEMBL1554143	=	Kd	nM	890.0	CHEMBL1770034	Homo sapiens	Kd	uM	0.89
	16372055	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Sc4nccs4)c23)c1		CHEMBL3729099	=	Kd	nM	1000.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.0
	16372056	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1csc(Sc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)n1		CHEMBL3727398	=	Kd	nM	1000.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.0
	16372057	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CCc1nnc(Sc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)o1		CHEMBL3729321	=	Kd	nM	1580.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.58
	16372058	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1cnc(Nc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)s1		CHEMBL3731638	=	Kd	nM	1580.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.58
	16372059	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Sc4ccncc4)c23)c1		CHEMBL3729792	=	Kd	nM	1780.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.78
	16372060	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Nc4nccs4)c23)c1		CHEMBL3730832	=	Kd	nM	1990.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.99
	16372061	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Sc4nncs4)c23)c1		CHEMBL3731120	=	Kd	nM	1990.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.99
	16372062	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Sc4nc5ccccc5[nH]4)c23)c1		CHEMBL3729376	=	Kd	nM	2240.0	CHEMBL1770034	Homo sapiens	Kd	uM	2.24
	16372063	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Nc4ccncc4)c23)c1		CHEMBL3731341	=	Kd	nM	2820.0	CHEMBL1770034	Homo sapiens	Kd	uM	2.82
	16372064	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Sc4nnc[nH]4)c23)c1		CHEMBL3732764	=	Kd	nM	3160.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.16
	16372065	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(-n4nc5ccccn5c4=S)c23)c1		CHEMBL3729001	=	Kd	nM	3160.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.16
	16372066	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CCc1nnc(Nc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)s1		CHEMBL3728003	=	Kd	nM	3160.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.16
	16372067	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Sc4nc5ccccc5s4)c23)c1		CHEMBL3729140	=	Kd	nM	3160.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.16
	16372068	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1cc(Nc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)n(C)n1		CHEMBL3730934	=	Kd	nM	3550.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.55
	16372069	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1csc(Nc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)n1		CHEMBL3729993	=	Kd	nM	3960.0	CHEMBL1770034	Homo sapiens	Kd	uM	3.96
	16372070	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1ncn(-c2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)c1=S		CHEMBL3727411	=	Kd	nM	5010.0	CHEMBL1770034	Homo sapiens	Kd	uM	5.01
	16372071	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1nnc(Nc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)s1		CHEMBL3732475	=	Kd	nM	5010.0	CHEMBL1770034	Homo sapiens	Kd	uM	5.01
	16372072	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1nnc(Sc2ncnc3scc(-c4cccc(S(C)(=O)=O)c4)c23)o1		CHEMBL3729186	=	Kd	nM	6310.0	CHEMBL1770034	Homo sapiens	Kd	uM	6.31
	16372073	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(NCc4ccccn4)c23)c1		CHEMBL3732136	=	Kd	nM	7080.0	CHEMBL1770034	Homo sapiens	Kd	uM	7.08
	16372074	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(NCCc4ccc(O)cc4)c23)c1		CHEMBL3730118	=	Kd	nM	7080.0	CHEMBL1770034	Homo sapiens	Kd	uM	7.08
	16372075	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Nc4ccncn4)c23)c1		CHEMBL3729616	=	Kd	nM	14120.0	CHEMBL1770034	Homo sapiens	Kd	uM	14.12
	16372076	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(NCc4ccncc4)c23)c1		CHEMBL3731056	=	Kd	nM	31620.0	CHEMBL1770034	Homo sapiens	Kd	uM	31.62
	16372683	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cc1occc1Sc1ncnc2scc(-c3cccc(S(C)(=O)=O)c3)c12		CHEMBL3730302	=	Kd	nM	31620.0	CHEMBL1770034	Homo sapiens	Kd	uM	31.62
	16372684	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(NCCCN)c23)c1		CHEMBL3731579	=	Kd	nM	39810.0	CHEMBL1770034	Homo sapiens	Kd	uM	39.81
	16372685	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(Sc4nnc5ccccn45)c23)c1		CHEMBL3728695	=	Kd	nM	50120.0	CHEMBL1770034	Homo sapiens	Kd	uM	50.12
	16372686	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1cnnc1Sc1ncnc2scc(-c3cccc(S(C)(=O)=O)c3)c12		CHEMBL3730668	=	Kd	nM	56230.0	CHEMBL1770034	Homo sapiens	Kd	uM	56.23
	16372687	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	CS(=O)(=O)c1cccc(-c2csc3ncnc(NCCN)c23)c1		CHEMBL3728741	>	Kd	nM	100000.0	CHEMBL1770034	Homo sapiens	Kd	uM	100.0
	16372688	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2[nH]nc(-c3ccccc3)c12		CHEMBL3731659	=	Kd	nM	7080.0	CHEMBL1770034	Homo sapiens	Kd	uM	7.08
	16372689	CHEMBL3734155	Inhibition of PIP5K2C (unknown origin)	B	Cn1nnnc1Sc1ncnc2[nH]nc(-c3cccc(S(C)(=O)=O)c3)c12		CHEMBL3730640	=	Kd	nM	1580.0	CHEMBL1770034	Homo sapiens	Kd	uM	1.58
	16643262	CHEMBL3826093	Inhibition of partial length human wild type PIP5K2C (M1 to A421 residues) expressed in mammalian expression system at 1 uM by KINOMEScan assay relative to control	B	CC(C)Oc1c(NC(=O)c2csc3c(=O)[nH]cnc23)cccc1C(=O)N1CCN(C)CC1		CHEMBL3823738	=	Inhibition	%	50.0	CHEMBL1770034	Homo sapiens	INH	%	50.0
Active	16673526	CHEMBL3855903	Inhibition of human PIP5K2C (M1 to A421 residues) expressed at 1 uM	B	C=CC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3979343		Inhibition	%		CHEMBL1770034	Homo sapiens	INH		
	16763144	CHEMBL3862733	Binding affinity to human PIP5K2C expressed in Escherichia coli BL21 cells incubated for 1 hr by active site directed binding competition assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	Kd	nM	480.0	CHEMBL1770034	Homo sapiens	Kd	nM	480.0
Inactive	17926606	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926607	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926608	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926609	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926610	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926611	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926612	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926613	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	1595.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	1595.0
Inactive	17926614	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926615	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926616	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926617	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926618	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17926619	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	3.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	3.0
Inactive	17926620	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926621	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926622	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926623	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926624	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926625	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926626	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926627	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926628	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926629	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926630	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926631	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926632	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926633	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926634	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926635	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926636	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926637	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926638	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926639	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926640	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926641	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926642	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926643	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926644	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926645	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926646	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926647	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926648	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926649	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	109.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	109.0
Inactive	17926650	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926651	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926652	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926653	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926654	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926655	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926656	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926657	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926658	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926659	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926660	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926661	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926662	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926663	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926664	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926665	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926666	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926667	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926668	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926669	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926670	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926671	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926672	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926673	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926674	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926675	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926676	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926677	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926678	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926679	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926680	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926681	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926682	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	2440.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	2440.0
Inactive	17926683	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926684	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926685	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926686	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926687	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926688	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926689	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926690	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926691	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926692	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1432.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	1432.0
Inactive	17926693	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926694	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17926695	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	=	Kd	nM	4974.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	4974.0
Active	17926696	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Kd	nM	2973.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	2973.0
Inactive	17926697	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926698	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926699	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926700	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926701	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926702	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	=	Kd	nM	1372.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	1372.0
Inactive	17926703	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926704	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926705	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926706	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926707	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926708	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926709	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Kd	nM	1721.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	1721.0
Uncertain	17926710	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	=	Kd	nM	4015.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	4015.0
Inactive	17926711	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926712	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926713	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926714	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926715	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926716	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926717	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	1112.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	1112.0
Inactive	17926718	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17926719	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	6185.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	6185.0
Inactive	17926720	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926721	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926722	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926723	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926724	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926725	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926726	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	Kd	nM	1027.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	1027.0
Inactive	17926727	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926728	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926729	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926730	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17926731	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2845.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	2845.0
Inactive	17926732	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926733	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17926734	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	2184.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	2184.0
Inactive	17926735	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926736	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926737	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926738	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926739	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926740	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926741	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926742	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926743	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	=	Kd	nM	4795.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	4795.0
Inactive	17926744	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926745	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926746	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926747	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926748	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	2635.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	2635.0
Inactive	17926749	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926750	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926751	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	2837.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	2837.0
Inactive	17926752	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926753	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926754	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926755	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926756	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926757	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926758	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926759	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926760	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926761	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926762	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926763	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926764	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926765	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926766	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926767	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926768	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926769	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926770	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926771	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926772	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926773	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926774	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926775	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926776	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926777	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926778	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926779	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926780	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926781	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926782	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926783	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926784	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926785	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926786	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926787	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926788	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926789	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926790	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926791	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926792	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926793	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926794	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926795	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926796	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	67.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	67.0
Inactive	17926797	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926798	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926799	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926800	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926801	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926802	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926803	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926804	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926805	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926806	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926807	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926808	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926809	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926810	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926811	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926812	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926813	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926814	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	2901.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	2901.0
Inactive	17926815	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926816	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	5572.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	5572.0
Inactive	17926817	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926818	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926819	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	4342.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	4342.0
Inactive	17926820	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926821	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926822	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926823	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926824	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926825	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926826	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926827	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926828	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926829	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926830	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926831	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926832	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	=	Kd	nM	320.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	320.0
Uncertain	17926833	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	331.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	331.0
Inactive	17926834	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926835	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926836	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926837	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926838	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926839	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926840	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926841	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926842	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Active	17926843	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	=	Kd	nM	4663.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	4663.0
Inactive	17926844	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926845	CHEMBL3991828	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL1770034	Homo sapiens	Kd apparent	nM	30000.0
	18074012	CHEMBL4015994	Inhibition of PIPK2C in human THP1 cell lysate at 200 nM	B	CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@H]1F		CHEMBL4081711	>	Inhibition	%	50.0	CHEMBL1770034	Homo sapiens	INH	%	50.0
	18114797	CHEMBL4025327	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	97.0	CHEMBL1770034	Homo sapiens	Activity	%	97.0
	18143372	CHEMBL4031767	Inhibition of PIP4K2C in human HCT116 cell lysate after 1 hr by LC-MS/MS analysis relative to control	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	=	IC50	nM	1100.0	CHEMBL1770034	Homo sapiens	IC50	uM	1.1
	18143375	CHEMBL4031764	Binding affinity to PIP4K2C in human HCT116 cell lysate at 3 uM after 1 hr by LC-MS/MS analysis	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	>=	Activity	%	75.0	CHEMBL1770034	Homo sapiens	Activity	%	75.0
	18153007	CHEMBL4034542	Inhibition of PIP4K2C (unknown origin) labeling at ATP binding site (VKELPTLDI) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	12.2	CHEMBL1770034	Homo sapiens	INH	%	12.2
	18153008	CHEMBL4034541	Inhibition of PIP4K2C (unknown origin) labeling at ATP binding site (AKELPTLKDI) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	14.6	CHEMBL1770034	Homo sapiens	INH	%	14.6
	18203851	CHEMBL4044138	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	6.3	CHEMBL1770034	Homo sapiens	Activity	%	6.3
	18211707	CHEMBL4045803	Inhibition of PIP4K2C ATP binding site (TLVIKEVSSEDIADMHSNLSNYHQYIVK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	6.4	CHEMBL1770034	Homo sapiens	INH	%	6.4
	18211948	CHEMBL4046044	Inhibition of PIP4K2C ATP binding site (TLVIKEVSSEDIADMHSNLSNYHQYIVK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-8.1	CHEMBL1770034	Homo sapiens	INH	%	-8.1
	18253919	CHEMBL4055244	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL1770034	Homo sapiens	Activity	%	100.0
	18253920	CHEMBL4055244	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL1770034	Homo sapiens	Activity	%	100.0
	18275223	CHEMBL4118453	Inhibition of PIP4K2C in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled TLVIKEVSSEDIADMHSNLSNYHQYIVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-20.2	CHEMBL1770034	Homo sapiens	INH	%	-20.2
	18275224	CHEMBL4118453	Inhibition of PIP4K2C in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled TLVIKEVSSEDIADMHSNLSNYHQYIVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-19.9	CHEMBL1770034	Homo sapiens	INH	%	-19.9
	18275225	CHEMBL4118453	Inhibition of PIP4K2C in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled TLVIKEVSSEDIADMHSNLSNYHQYIVK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	16.8	CHEMBL1770034	Homo sapiens	INH	%	16.8
	18407917	CHEMBL4151473	Inhibition of human PIP5K2C expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	28.0	CHEMBL1770034	Homo sapiens	Activity	%	28.0
	18407958	CHEMBL4151473	Inhibition of human PIP5K2C expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	5.0	CHEMBL1770034	Homo sapiens	Activity	%	5.0
	18408003	CHEMBL4151473	Inhibition of human PIP5K2C expressed in mammalian expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	36.0	CHEMBL1770034	Homo sapiens	Activity	%	36.0
	18440393	CHEMBL4157217	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	78.0	CHEMBL1770034	Homo sapiens	Activity	%	78.0
	18484349	CHEMBL4185996	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	56.0	CHEMBL1770034	Homo sapiens	Activity	%	56.0
	18484833	CHEMBL4185996	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL1770034	Homo sapiens	Activity	%	100.0
	18655339	CHEMBL4230896	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	37.0	CHEMBL1770034	Homo sapiens	Activity	%	37.0
	18752148	CHEMBL4264485	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	59.0	CHEMBL1770034	Homo sapiens	Activity	%	59.0
	18858148	CHEMBL4307994	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	83.0	CHEMBL1770034	Homo sapiens	Activity	%	83.0
	18958612	CHEMBL4333579	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL1770034	Homo sapiens	Activity	%	100.0
	19009377	CHEMBL4345240	Inhibition of PI5P4Kgamma (unknown origin)	B	Cn1nnnc1Sc1ncnc2scc(-c3cccc(S(C)(=O)=O)c3)c12		CHEMBL1378392	=	IC50	nM	15800.0	CHEMBL1770034	Homo sapiens	IC50	uM	15.8
	19009378	CHEMBL4345240	Inhibition of PI5P4Kgamma (unknown origin)	B	FC(F)(F)c1ccccc1-c1nc(NCc2cccs2)c2ccccc2n1		CHEMBL1529478	=	IC50	nM	1000.0	CHEMBL1770034	Homo sapiens	IC50	uM	1.0
	19059773	CHEMBL4358074	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL1770034	Homo sapiens	Activity	%	100.0
	19090337	CHEMBL4365911	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	14.0	CHEMBL1770034	Homo sapiens	Activity	%	14.0
	19159601	CHEMBL4382705	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	90.0	CHEMBL1770034	Homo sapiens	Activity	%	90.0
	19191406	CHEMBL4389424	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	48.0	CHEMBL1770034	Homo sapiens	INH	%	48.0
	19192087	CHEMBL4389901	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	83.0	CHEMBL1770034	Homo sapiens	INH	%	83.0
	19200343	CHEMBL4391527	Binding affinity to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	3.4	CHEMBL1770034	Homo sapiens	Activity	%	3.4
Not Active	19269500	CHEMBL4406344	Binding affinity to partial length human PI5P4IKgamma expressed in mammalian system at 1 uM by KINOMEscan assay	B	CS(=O)(=O)Nc1ccc(-c2cncc(/C=C3\SC(=O)NC3=O)c2)cc1		CHEMBL4447308		Activity			CHEMBL1770034	Homo sapiens	Activity		
Not Active	19269508	CHEMBL4406348	Inhibition of human PI5P4IKgamma	B	CS(=O)(=O)Nc1ccc(-c2cncc(/C=C3\SC(=O)NC3=O)c2)cc1		CHEMBL4447308		Inhibition	%		CHEMBL1770034	Homo sapiens	INH		
	19269509	CHEMBL4406349	Binding affinity to human PI5P4IKgamma	B	CS(=O)(=O)Nc1ccc(-c2cncc(/C=C3\SC(=N)NC3=O)c2)cc1		CHEMBL4436648	=	Kd	nM	1.6	CHEMBL1770034	Homo sapiens	Kd	nM	1.6
	19269510	CHEMBL4406349	Binding affinity to human PI5P4IKgamma	B	CS(=O)(=O)Nc1ccc(-c2cncc(-c3cccc4[nH]ccc34)c2)cc1		CHEMBL4455633	=	Kd	nM	3.4	CHEMBL1770034	Homo sapiens	Kd	nM	3.4
	19269511	CHEMBL4406349	Binding affinity to human PI5P4IKgamma	B	CS(=O)(=O)Nc1ccc(-c2cc(/C=C3\SC(=N)NC3=O)cnc2N)cc1		CHEMBL4454033	=	Kd	nM	0.023	CHEMBL1770034	Homo sapiens	Kd	pM	23.0
	19269512	CHEMBL4406349	Binding affinity to human PI5P4IKgamma	B	CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2cccc(Nc3cc(-c4c[nH]c5ccccc45)ncn3)c2)cc1		CHEMBL4446338	=	Kd	nM	4.8	CHEMBL1770034	Homo sapiens	Kd	nM	4.8
	20669016	CHEMBL4620275	Inhibition of biotinylated ligand binding to wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cncc(Cl)c5)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4648955	>	Inhibition	%	80.0	CHEMBL1770034	Homo sapiens	INH	%	80.0
	22455690	CHEMBL4681970	Inhibition of PIP4K2C human PBMC lysates at 1 uM by ActivX screen assay relative to control	B	CC(C)(Oc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cc1)C(=O)O		CHEMBL4746566	>	Inhibition	%	70.0	CHEMBL1770034	Homo sapiens	INH	%	70.0
	23120914	CHEMBL4804470	Inhibition of PIP4K2C in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	42000.0	CHEMBL1770034	Homo sapiens	IC50	uM	42.0
	23120915	CHEMBL4804470	Inhibition of PIP4K2C in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	11800.0	CHEMBL1770034	Homo sapiens	IC50	uM	11.8
	23120916	CHEMBL4804470	Inhibition of PIP4K2C in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	79700.0	CHEMBL1770034	Homo sapiens	IC50	uM	79.7
	23120917	CHEMBL4804470	Inhibition of PIP4K2C in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	85400.0	CHEMBL1770034	Homo sapiens	IC50	uM	85.4
	23120918	CHEMBL4804470	Inhibition of PIP4K2C in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	90200.0	CHEMBL1770034	Homo sapiens	IC50	uM	90.2
	23120919	CHEMBL4804470	Inhibition of PIP4K2C in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	65700.0	CHEMBL1770034	Homo sapiens	IC50	uM	65.7
	23121954	CHEMBL4804652	Inhibition of PIP4K2C in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	35.0	CHEMBL1770034	Homo sapiens	INH	%	35.0
	23121955	CHEMBL4804652	Inhibition of PIP4K2C in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL1770034	Homo sapiens	INH	%	0.0
	23121956	CHEMBL4804652	Inhibition of PIP4K2C in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	75.0	CHEMBL1770034	Homo sapiens	INH	%	75.0
	23121957	CHEMBL4804652	Inhibition of PIP4K2C in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	75.0	CHEMBL1770034	Homo sapiens	INH	%	75.0
	23121958	CHEMBL4804652	Inhibition of PIP4K2C in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	>	Inhibition	%	90.0	CHEMBL1770034	Homo sapiens	INH	%	90.0
	23121959	CHEMBL4804652	Inhibition of PIP4K2C in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	50.0	CHEMBL1770034	Homo sapiens	INH	%	50.0
	23122758	CHEMBL4805109	Inhibition of human PIP5K2C assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	84.0	CHEMBL1770034	Homo sapiens	Activity	%	84.0
	23123453	CHEMBL4805697	Inhibition of human PIP5K2C assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	80.0	CHEMBL1770034	Homo sapiens	Activity	%	80.0
	23123908	CHEMBL4806152	Inhibition of DNA-tagged human PIP5K2C assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	55.0	CHEMBL1770034	Homo sapiens	Activity	%	55.0
	23124996	CHEMBL4806714	Inhibition of human PIP5K2C assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL1770034	Homo sapiens	Activity	%	80.0
	23124997	CHEMBL4806714	Inhibition of human PIP5K2C assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	64.0	CHEMBL1770034	Homo sapiens	Activity	%	64.0
	23234035	CHEMBL4827614	Inhibition of wild-type human partial length PIP5K2C (M1 to A421 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	<	Activity	%	10.0	CHEMBL1770034	Homo sapiens	Activity	%	10.0
Not Active	23317594	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	83.0	CHEMBL1770034	Homo sapiens	% Control	%	83.0
Not Active	23318062	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	85.0	CHEMBL1770034	Homo sapiens	% Control	%	85.0
Not Active	23318728	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	87.0	CHEMBL1770034	Homo sapiens	% Control	%	87.0
Not Active	23319212	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL1770034	Homo sapiens	% Control	%	96.0
Not Active	23319849	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23320324	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	80.7	CHEMBL1770034	Homo sapiens	% Control	%	80.7
Not Active	23321002	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	86.0	CHEMBL1770034	Homo sapiens	% Control	%	86.0
Not Active	23321470	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	81.0	CHEMBL1770034	Homo sapiens	% Control	%	81.0
Slightly Active	23322100	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	49.0	CHEMBL1770034	Homo sapiens	% Control	%	49.0
Not Active	23322568	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	94.0	CHEMBL1770034	Homo sapiens	% Control	%	94.0
Not Active	23323257	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	83.0	CHEMBL1770034	Homo sapiens	% Control	%	83.0
Not Active	23323725	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	83.0	CHEMBL1770034	Homo sapiens	% Control	%	83.0
Not Active	23324579	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23325214	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23325682	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	89.0	CHEMBL1770034	Homo sapiens	% Control	%	89.0
Not Active	23326329	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23326797	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	62.0	CHEMBL1770034	Homo sapiens	% Control	%	62.0
Not Active	23327497	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23327965	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23328552	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23329020	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	76.0	CHEMBL1770034	Homo sapiens	% Control	%	76.0
Not Active	23329966	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23330434	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23331190	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	96.0	CHEMBL1770034	Homo sapiens	% Control	%	96.0
Not Active	23331658	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	89.0	CHEMBL1770034	Homo sapiens	% Control	%	89.0
Not Active	23332245	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	89.9	CHEMBL1770034	Homo sapiens	% Control	%	89.9
Not Active	23332711	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	99.1	CHEMBL1770034	Homo sapiens	% Control	%	99.1
Not Active	23333429	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	80.7	CHEMBL1770034	Homo sapiens	% Control	%	80.7
Not Active	23334068	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	92.0	CHEMBL1770034	Homo sapiens	% Control	%	92.0
Not Active	23334536	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23335515	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23335983	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	96.0	CHEMBL1770034	Homo sapiens	% Control	%	96.0
Not Active	23336610	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23337078	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23338159	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23338627	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23339239	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23339707	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23340344	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Active	23340812	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	0.0	CHEMBL1770034	Homo sapiens	% Control	%	0.0
Not Active	23341469	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23341937	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	94.0	CHEMBL1770034	Homo sapiens	% Control	%	94.0
Not Active	23342553	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23343021	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23343651	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	95.0	CHEMBL1770034	Homo sapiens	% Control	%	95.0
Not Active	23344119	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	63.0	CHEMBL1770034	Homo sapiens	% Control	%	63.0
Not Active	23344757	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23345330	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	89.0	CHEMBL1770034	Homo sapiens	% Control	%	89.0
Not Active	23345798	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23346375	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	91.9	CHEMBL1770034	Homo sapiens	% Control	%	91.9
Not Active	23346843	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	97.5	CHEMBL1770034	Homo sapiens	% Control	%	97.5
Not Active	23347445	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	95.0	CHEMBL1770034	Homo sapiens	% Control	%	95.0
Not Active	23347935	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23348514	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23348982	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23349569	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23350187	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23350655	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23351260	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23351728	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23352752	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	90.0	CHEMBL1770034	Homo sapiens	% Control	%	90.0
Not Active	23353220	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	98.0	CHEMBL1770034	Homo sapiens	% Control	%	98.0
Not Active	23354102	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23354570	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23355302	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	92.0	CHEMBL1770034	Homo sapiens	% Control	%	92.0
Not Active	23355770	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	96.0	CHEMBL1770034	Homo sapiens	% Control	%	96.0
Not Active	23356406	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23356874	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23357483	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	81.0	CHEMBL1770034	Homo sapiens	% Control	%	81.0
Not Active	23358130	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	75.0	CHEMBL1770034	Homo sapiens	% Control	%	75.0
Not Active	23358598	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23359184	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	74.7	CHEMBL1770034	Homo sapiens	% Control	%	74.7
Not Active	23359782	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23360250	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	85.0	CHEMBL1770034	Homo sapiens	% Control	%	85.0
Not Active	23360835	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	66.0	CHEMBL1770034	Homo sapiens	% Control	%	66.0
Not Active	23361303	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23361876	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23362412	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Active	23362880	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	0.3	CHEMBL1770034	Homo sapiens	% Control	%	0.3
Not Active	23364522	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	85.0	CHEMBL1770034	Homo sapiens	% Control	%	85.0
Not Active	23364990	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23365729	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23366272	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23366862	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23367330	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	99.0	CHEMBL1770034	Homo sapiens	% Control	%	99.0
Not Active	23368208	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	86.0	CHEMBL1770034	Homo sapiens	% Control	%	86.0
Not Active	23368676	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	94.0	CHEMBL1770034	Homo sapiens	% Control	%	94.0
Not Active	23369275	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	96.0	CHEMBL1770034	Homo sapiens	% Control	%	96.0
Not Active	23369743	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	95.0	CHEMBL1770034	Homo sapiens	% Control	%	95.0
Not Active	23370711	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	77.0	CHEMBL1770034	Homo sapiens	% Control	%	77.0
Not Active	23371179	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	92.0	CHEMBL1770034	Homo sapiens	% Control	%	92.0
Not Active	23371988	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23372456	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23375883	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23376351	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23376928	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	98.0	CHEMBL1770034	Homo sapiens	% Control	%	98.0
Not Active	23377396	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23378256	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	93.0	CHEMBL1770034	Homo sapiens	% Control	%	93.0
Not Active	23378724	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23379891	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	99.0	CHEMBL1770034	Homo sapiens	% Control	%	99.0
Not Active	23380359	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	58.0	CHEMBL1770034	Homo sapiens	% Control	%	58.0
Not Active	23381053	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23381701	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Not Active	23382169	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL1770034	Homo sapiens	% Control	%	100.0
Slightly Active	23382793	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	40.0	CHEMBL1770034	Homo sapiens	% Control	%	40.0
Slightly Active	23383261	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	42.0	CHEMBL1770034	Homo sapiens	% Control	%	42.0
Not Active	23385176	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL1770034	Homo sapiens	% Control	%	91.0
Not Active	23385643	CHEMBL4879900	KinomeScan assay: inhibition of PIP5K2C	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	58.0	CHEMBL1770034	Homo sapiens	% Control	%	58.0
